Recently, genome-wide association studies identified that triggering receptor expressed on myeloid cells 2 (TREM2) is one of the strongest genetic risk factors for AD, following APP, PSEN1, and APOE [7, 8]. The gene discussed is APOE; the disease is Alzheimer disease.